Skip to main content
. Author manuscript; available in PMC: 2015 May 1.
Published in final edited form as: Circ Heart Fail. 2014 Apr 15;7(3):401–408. doi: 10.1161/CIRCHEARTFAILURE.113.000840

Figure 1.

Figure 1

Analytic cohort. EVEREST indicates Efficacy of Vasopressin Antagonist in Heart Failure Outcome Study with Tolvaptan; and Hgb, hemoglobin.